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NMOSD develops primarily in women of childbearing age, and several previous studies have 
shown that the disorder may increase the risk of miscarriage. However, there are no reports, to 
our knowledge, of fetal malformation, other than neonatal hydrocephalus, related to NMOSD. 
We report a 30-year-old woman who experienced recurrent neuritis and who was seropositive 
for AQP4-IgG. She became pregnant, and the fetus was found to have ectrodactyly. Histological 
analysis of the placenta showed moderate inflammatory infiltration; however, whether fetal 
malformation in NMOSD is related to inflammation and AQP4-IgG remains to be determined. 
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1. Introduction 
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease of the central 
nervous system, and circulating antibodies against aquaporin 4 (AQP4, AQP4-IgG) is a critically 
important feature of NMOSD (Papadopoulos and Verkman, 2012). NMOSD develops primarily in 
women of childbearing age; therefore, research to determine whether NMOSD affects pregnancy 
outcomes has received increasing attention. Several animal studies and some clinical cases have 
shown that AQP4-IgG may increase the risk of miscarriage in NMOSD patients(Huang et al., 2017; 
Nour et al., 2016; Ratelade et al., 2011; Saadoun et al., 2013); however, to our knowledge, there 
are no previous reports of fetal malformation related to NMOSD (Huang et al., 2017; Nour et al., 
2016). We report a Chinese NMOSD patient whose fetus suffered malformation during pregnancy, 
and discuss the placental pathological findings. 
 
2. Case report 
Fetal malformation was identified in a 30-year-old southern Chinese female NMOSD patient 
based on ultrasound examination at 24-weeks’ pregnancy in May, 2017. She had no family history 
of fetal malformation, had no contact with poisonous substances or radioactivity during 
pregnancy, and she was not infected by Toxoplasma or viruses. Her symptoms first appeared as 
right eye vision impairment when she was 17-years old, in 2004. In 2013, she suffered repeat 
optic neuritis of the right eye at 4-weeks’ gestation when she elected induced abortion and 
began to take continuous low-dose glucocorticoid therapy. In July,2014, she experienced right eye 
vision loss for the third time. Her serum AQP4-IgG titer was positive (1:32), and she was 
diagnosed as having NMOSD and began to take azathioprine 50mg and methylprednisolone 8mg 
per day. In preparation for pregnancy, she discontinued azathioprine while continuing 
methylprednisolone 8mg daily, in August 2016. She also began to take folic acid and Vitamin E in 
September, 2016. Her last menstrual period before becoming pregnant was September 16th,2016. 
In February 2017, she experienced transient mild vaginal bleeding and was diagnosed with 
threatened abortion. Dydrogesterone 10mg was prescribed every 8 hours for 2 weeks, and 
methylprednisolone was added at 16mg per day until March, 2017, when it was reduced to 12mg 
per day. On May 31st, 2017, the fetus was found to have ectrodactyly, based on ultrasound 
examination, and the patient elected induced labor on June 6th. The fetus’ height and weight 
were within normal range in same gestational age (Height 32cm, Weight 0.885kg) and the 
appearance of face and trunk were normal, too. However. It had ectrodactyly in both hands and 
the left foot (Fig. 1A,B,C). Macroscopic pathological examination revealed a normal placenta, and 
histological examination of the placenta showed moderate inflammation (Fig. 1D,E,F,G,H). 
Chromosomal analysis of the infant showed no deficiency or repetition of chromosome 
fragments larger than 0.4Mbp, and fluorescence in situ hybridization found no aneuploidy of 
chromosome 21, 18, 13, X, or Y. Whole exome sequencing of the fetus revealed no clinically 
relevant causal variant. This study was approved by the Ethics Committee of The Third Affiliated 
Hospital of SUN Yat-sen University. Written informed consent was obtained from the patient to 
donate the placenta and publish her case report and accompanying images.  
 
3. Discussion 
To our knowledge, this is the first case report describing fetal limb malformation in NMOSD. 
Ectrodactyly is a rare congenital disorder in which the development of the hands and feet are 
disturbed. Ectrodactyly can be isolated or associated with other anomalies in some syndromes, 
including single gene mutations, chromosomal rearrangements, and possibly digenic inheritance, 
as well as early amnion rupture disruption sequence(Kalathia et al., 2013; Wilcox et al., 2015).  
While in this case, there was no causal variant found in the fetus. Exposure to certain drugs was 
also reported to cause limb malformations(Sanders et al., 1991). There was one infant born with 
preaxial polydactyly to a mother taking azathioprine throughout pregnancy reported 
before(Williamson and Karp., 1981), but several studies showed that the use of azathioprine may 
not increase the rate of fetus malformation, even in early pregnancy(Cleary and Kallen., 2009; 
Saavedra et al., 2015; Hoeltzenbein et al., 2012). Besides in this case, the patient discontinued 
azathioprine before pregnancy, therefore the possibility that the malformation was associated 
with the use of azathioprine was low.  
 
AQP4-IgG-seropositive patients may have a higher risk of miscarriage. Saadounet al showed in 
animal experiments that AQP4-IgG can bind placental AQP4, activate complement, and cause 
inflammatory cell infiltration then miscarriage (Saadoun et al., 2013). Placental immunostaining 
from an NMOSD patient who had a spontaneous miscarriage showed complete loss of AQP4 and 
diffuse, mainly perivascular, deposits of membrane attack complexes in the syncytiotrophoblasts 
(Reuss et al., 2009). Cases of neonatal hydrocephalus in NMOSD patients have also been reported 
(Huang et al., 2017; Nour et al., 2016). Neonatal hydrocephalus may be caused by disturbances in 
fetal CNS fluid balance related to AQP4-IgG, but this has not been confirmed, pathologically. In 
our case, placental AQP4 loss was not obvious, but moderate inflammatory cell infiltration was 
seen. 
 
In early gestation, multiple aquaporin proteins are expressed in the human embryo, and these 
play important roles in embryonic development(Xiong et al., 2013). AQP4-IgG can reach the fetal 
circulatory system through the placenta; however, it is not known whether AQP4-IgG can disturb 
fetal development and cause fetal malformation.  
 
In conclusion, it is important to be aware of NMOSD-related fetal malformation. Further study is 
needed to determine whether NMOSD can cause fetal malformation by AQP4-IgG-induced 
inflammation and its sequelae. 
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Fig.1 Macroscopical manifestation of the fetus and histological evaluation of the placenta. A–C. 
Hands and feet of the fetus showing deficiencies in the proximal and intermediate phalanges of 
the 3rd, 4th, and 5th fingers of the right hand (A), 2nd, 3rd, 4th, and 5th fingers of the left hand (B), 
and3rd, 4th, and 5th toes of the left foot (C). D. Photomicrograph of hematoxylin and eosin staining 
of the placenta showing normal structure of the chorionic villi (×100); E. AQP4 immunostaining 
showing no obvious loss of immunoreactivity in trophoblasts (arrows indicate 
AQP4-immunostaining-positive trophoblast cells, ×400); F. CD20 immunostaining showing 
B-lymphocyte infiltration into villi (arrow indicates a typical CD20-immunostaining-positive cell, 
×400); G. CD68 immunostaining showing macrophage infiltration into villi (arrows indicate typical 
CD68-immunostaining-positive cells, ×400); H.c5b-9 immunostaining showing moderate 





 This is the first case report describing fetal limb malformation in NMOSD.  
 Moderate inflammatory infiltration was found in the patient’s placenta. 
 Whether fetal malformation in NMOSD is related to inflammation and AQP4-IgG 
remains to be determined. 
 We should be aware of NMOSD-related fetal malformation. 
 
